Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma

Mathew R. Birnbaum, Michelle W. Ma, Sarah Fleisig, Stuart Packer, Bijal D. Amin, Mark Jacobson, Beth N. McLellan

Research output: Contribution to journalArticlepeer-review

64 Scopus citations
Original languageEnglish (US)
Pages (from-to)208-211
Number of pages4
JournalJAAD Case Reports
Issue number3
StatePublished - May 1 2017


  • immune checkpoint inhibitors
  • immune-related adverse events
  • immunotherapy
  • nivolumab
  • programmed cell death-1
  • sarcoidosis

ASJC Scopus subject areas

  • Dermatology

Cite this